Shanghai, China
At LYFE, we share the passion of our entrepreneurs in their objectives of striving for a better world; one step at a time. Not only do we invest in healthcare but we also bring significant deep seated Asia knowledge and international business experience to accelerate our partners in their growth, expanding a strong stable company more readily to take on the challenges in the Asia market.
45
Total Investments
36
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About LYFE Capital
Recent Investments (45)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Nov 2025 | |
| Late Vc | •••••• | Apr 2025 | |
| Series A | •••••• | Jan 2025 | |
| Post-IPO Equity | •••••• | Mar 2024 | |
| Angel Round | •••••• | Jan 2024 | |
•••• ••••
|
Series B | •••••• | Aug 2023 |
|
•••• ••••
|
Series B | •••••• | Aug 2023 |
|
•••• ••••
|
Series B | •••••• | Apr 2023 |
|
•••• ••••
|
Series D | •••••• | Jan 2023 |
|
•••• ••••
|
Series A - Dieshi | •••••• | Dec 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
